Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose some weight.

University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, according to an analysis of real-world data shared with Reuters that sheds ...

Obesity is widely regarded as a major risk factor for other chronic diseases. Read more at straitstimes.com. Read more at straitstimes.com.

Dr Elise Dallas, GP at The London General Practice, explains how these medications impact our bodies and what happens after you stop taking them.

U.S. airlines stand to reap the benefits as more passengers slim down thanks to the popularity of GLP-1 weight-loss drugs.

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

The American Heart Association recommends systemic solutions beyond diet, exercise, and costly weight-loss drugs to address the social, economic, and environmental barriers that drive obesity, which ...

Patients who stop taking popular injectable weight-loss medications typically regain much of the weight they lost within two ...

The past couple of years have been challenging for the company. But this could be the beginning of a new chapter.

Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...